Physician profile
Christopher J Kavanagh
NPI 1932179959
$2,561.57
in general payments reported to CMS, 2019-2025
11 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $227 · 2021: $204 · 2022: $611 · 2023: $426 · 2024: $451 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241 · Entertainment: $48.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.05 |
| Entertainment | $48.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,442.22 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $389.79 | 2019-2025 | Dailies Total1, Total30, Precision7 |
| Visioneering Technologies, INC. | $219.58 | 2021-2025 | |
| Coopervision INC. | $216.32 | 2019-2025 | Myday Contact Lens, Paragon Crt, Onefit Contact Lens |
| Bausch & Lomb Americas INC. | $120.36 | 2022-2025 | Infuse, Biotrue One Day |
| Optos, INC. | $70.34 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Menicon America INC | $24.66 | 2019 | |
| Oyster Point Pharma, INC. | $23.84 | 2022 | |
| Plexus Optix, INC. | $22.20 | 2019 | |
| Sun Pharmaceutical Industries INC. | $18.84 | 2021 | |
| Abb Con-Cise Optical Group LLC | $13.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kavanagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.